Linezolid - The First Oxazolidinone in the Treatment of Nosocomial MRSA Pneumonia

E-ISSN： 2212-4071|2|2|123-130

ISSN： 1574-891X

Source： Recent Patents on Anti-Infective Drug Discovery, Vol.2, Iss.2, 2007-06, pp. : 123-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PEGylated Liposomal Vancomycin: A Glimmer of Hope for Improving Treatment Outcomes in MRSA Pneumonia

Recent Patents on Anti-Infective Drug Discovery, Vol. 7, Iss. 3, 2012-10 ,pp. : 205-212

Bentham Science Publishers

Access to resources Recommend Favorite

Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia

By Muller Anouk E. Punt Nieko Mouton Johan W.

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 4, 2013-04 ,pp. : 900-906

Oxford University Press

Access to resources Recommend Favorite

Nosocomial Pneumonia: Rationalizing the Approach to Empirical Therapy

By Andriesse Gunnar I. Verhoef Jan

Treatments in Respiratory Medicine, Vol. 5, Iss. 1, 2006-01 ,pp. : 11-30

Adis International

Access to resources Recommend Favorite

Pneumonia Due to Methicilin-Resistant Staphylococcus aureus (MRSA): A Review

Current Respiratory Medicine Reviews, Vol. 8, Iss. 3, 2012-06 ,pp. : 245-258

Bentham Science Publishers

Access to resources Recommend Favorite

Community-Associated Methicillin Resistant Staphylococcus aureus Pneumonia (CA-MRSA)

Current Respiratory Medicine Reviews, Vol. 6, Iss. 3, 2010-08 ,pp. : 194-200

Bentham Science Publishers

Access to resources Recommend Favorite